Saudi Pharmaceutical Industries and Medical Appliances Corporation

SASE:2070 Voorraadrapport

Marktkapitalisatie: ر.س3.7b

Saudi Pharmaceutical Industries and Medical Appliances Toekomstige groei

Future criteriumcontroles 4/6

Saudi Pharmaceutical Industries and Medical Appliances zal naar verwachting groeien in winst en omzet met respectievelijk 35.1% en 9.6% per jaar. De winst per aandeel zal naar verwachting groeien met 42.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.8% zijn.

Belangrijke informatie

35.1%

Groei van de winst

42.9%

Groei van de winst per aandeel

Pharmaceuticals winstgroei16.7%
Inkomstengroei9.6%
Toekomstig rendement op eigen vermogen14.8%
Dekking van analisten

Low

Laatst bijgewerkt07 Oct 2024

Recente toekomstige groei-updates

Recent updates

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations

Nov 24
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Sep 05
Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14
Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02
Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12
One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20
A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30
Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23
Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19
What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Winst- en omzetgroeiprognoses

SASE:2070 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (SAR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262,2191881922434
12/31/20252,0081451462014
12/31/20241,80810139-3924
9/30/20241,62823-266-156N/A
6/30/20241,562-18-6078N/A
3/31/20241,597-4035152N/A
12/31/20231,653-20-7048N/A
9/30/20231,686-76-3052N/A
6/30/20231,662-78-607N/A
3/31/20231,564-142-213-136N/A
12/31/20221,422-152-178-99N/A
9/30/20221,425-94-195-109N/A
6/30/20221,379-42-229-136N/A
3/31/20221,39438-1073N/A
12/31/20211,46030987N/A
9/30/20211,47157-10218N/A
6/30/20211,532117-145-24N/A
3/31/20211,534110-172-23N/A
12/31/20201,555130-16510N/A
9/30/20201,521-11444278N/A
6/30/20201,491-153241505N/A
3/31/20201,518-365-37275N/A
12/31/20191,487-43418352N/A
9/30/20191,743-163-164138N/A
6/30/20191,626-204-461-165N/A
3/31/20191,5666-27110N/A
12/31/20181,50374-355-74N/A
9/30/20181,31366-280-42N/A
6/30/20181,36661N/A25N/A
3/31/20181,37585N/A103N/A
12/31/20171,386139N/A155N/A
9/30/20171,315274N/A205N/A
6/30/20171,295296N/A118N/A
3/31/20171,329289N/A-21N/A
12/31/20161,259277N/A-94N/A
9/30/20161,448124N/A-281N/A
6/30/20161,499149N/A-134N/A
3/31/20161,595347N/A-53N/A
12/31/20151,705357N/A-38N/A
9/30/20151,604457N/A115N/A
6/30/20151,562465N/A44N/A
3/31/20151,500325N/A12N/A
12/31/20141,470317N/A43N/A
9/30/20141,424283N/A-94N/A
6/30/20141,381279N/A-79N/A
3/31/20141,351295N/A79N/A
12/31/20131,311267N/A54N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 2070 ( 35.1% per jaar) ligt boven de spaarquote ( 14.7% ).

Winst versus markt: De winst van 2070 ( 35.1% per jaar) zal naar verwachting sneller groeien dan de SA markt ( 6.5% per jaar).

Hoge groeiwinsten: De winst van 2070 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van 2070 ( 9.6% per jaar) zal naar verwachting sneller groeien dan de markt SA ( -0.2% per jaar).

Hoge groei-inkomsten: De omzet van 2070 ( 9.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 2070 zal naar verwachting over 3 jaar laag zijn ( 14.8 %).


Ontdek groeibedrijven